DiaMedica Therapeutics
DMAC
DMAC
23 hedge funds and large institutions have $21M invested in DiaMedica Therapeutics in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$898K | |
| 2 | +$372K | |
| 3 | +$352K | |
| 4 |
Bank of New York Mellon
New York
|
+$60.1K |
| 5 |
BlackRock
New York
|
+$27.4K |
Top Sellers
| 1 | -$700K | |
| 2 | -$296K | |
| 3 | -$35.3K | |
| 4 |
Millennium Management
New York
|
-$30K |
| 5 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
-$8K |